Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19

NACompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Diabetes Mellitus, Type 2Covid19
Interventions
BEHAVIORAL

Hospital: DD-CA

In the DD-CA group, participants will be offered a proven digital texting platform in their language of preference (Spanish/English) as part of the diabetes transitions discharge program with educational, motivational and medication adherence messaging that is currently an arm of our parent DD-ME grant with added COVID support messages that provide information addressing identified barriers in Hispanic underserved communities (e.g. obtaining testing supplies and medications, accessing routine medical care, and completing other important diabetes self-management behaviors such as healthful eating, exercise, social distancing, quarantine, and stay-at-home/lockdown guidelines).

BEHAVIORAL

Hospital: Usual Care (UC)

In the UC group, participants will not receive the added COVID support messages, both groups will have a referral placed to the Diabetes Transitions Service (DTS) at the time of discharge as part of usual care. Participants will be contacted by a peer health coach following protocol to coordinate care with outpatient health and other community resources.

Trial Locations (1)

91910

Scripps Mercy Hospital Chula Vista, Chula Vista

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Scripps Whittier Diabetes Institute

OTHER

NCT04591015 - Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19 | Biotech Hunter | Biotech Hunter